Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-07-04 08:00 |
Valneva announces the successful completion of its €40 million capital increase…
|
English | 265.7 KB | ||
| 2013-07-04 08:00 |
Valneva annonce le succès de son augmentation de capital de €40 millions - opér…
|
French | 266.7 KB | ||
| 2013-06-21 09:06 |
Le Centre américain de Contrôle et de prévention des maladies (CDC) étend l'uti…
|
French | 229.9 KB | ||
| 2013-06-21 09:06 |
ACIP Unanimously Votes to Extend the Recommendations for Use of IXIARO®Vaccine
|
English | 254.0 KB | ||
| 2013-06-21 08:52 | English | 12.4 KB | |||
| 2013-06-13 08:12 | German | 13.0 KB | |||
| 2013-06-13 08:12 | English | 12.8 KB | |||
| 2013-06-13 08:00 |
Valneva annonce le lancement d'une augmentation de capital, garantie intégralem…
|
French | 123.7 KB | ||
| 2013-06-13 08:00 |
Valneva announces launch of a fully underwritten €40 million capital increase w…
|
English | 122.3 KB | ||
| 2013-06-10 17:50 |
VALNEVA : ACTIONS ET DROITS DE VOTE MAI 2013
|
French | 133.5 KB | ||
| 2013-06-07 08:00 |
Valneva SE announces the sale of its Clinical Manufacturing Operations (CMO) in…
|
English | 247.6 KB | ||
| 2013-06-07 08:00 |
Valneva SE annonce la cession de son activité française de bioproduction à la s…
|
French | 249.7 KB | ||
| 2013-05-28 10:52 | English | 417.3 KB | |||
| 2013-05-28 10:52 | German | 318.0 KB | |||
| 2013-05-28 09:40 |
Completion of Merger between Vivalis and Intercell to form Valneva
|
English | 417.3 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
